Drug Type Antibody |
Synonyms- |
Target |
Mechanism SARS-CoV-2 S protein neutralization |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | CN | 15 Jun 2023 | |
COVID-19 | Preclinical | CN | 15 Jun 2023 |